123 related articles for article (PubMed ID: 36920918)
21. Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies.
Ouattara EN; Robine M; Eholié SP; MacLean RL; Moh R; Losina E; Gabillard D; Paltiel AD; Danel C; Walensky RP; Anglaret X; Freedberg KA
Clin Infect Dis; 2016 Jun; 62(11):1454-1462. PubMed ID: 26936666
[TBL] [Abstract][Full Text] [Related]
22. "After viral load testing, I get my results so I get to know which path my life is taking me": qualitative insights on routine centralized and point-of-care viral load testing in western Kenya from the Opt4Kids and Opt4Mamas studies.
Qian SRW; Hassan SA; Scallon AJ; Oyaro P; Brown E; Wagude J; Mukui I; Kinywa E; Oluoch F; Odhiambo F; Oyaro B; Kingwara L; Yongo N; Karauki E; Gao J; Otieno L; John-Stewart GC; Abuogi LL; Patel RC
BMC Health Serv Res; 2022 Dec; 22(1):1540. PubMed ID: 36528677
[TBL] [Abstract][Full Text] [Related]
23. Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire.
Boyd A; Moh R; Gabillard D; le Carrou J; Danel C; Anglaret X; Eholié SP; Maylin S; Delaugerre C; Zoulim F; Girard PM; Lacombe K;
Antivir Ther; 2015; 20(6):643-54. PubMed ID: 25852125
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and factors associated with physical function limitation in older West African people living with HIV.
Bernard C; Font H; Diallo Z; Ahonon R; Tine JM; Abouo F; Tanon A; Messou E; Seydi M; Dabis F; de Rekeneire N;
PLoS One; 2020; 15(10):e0240906. PubMed ID: 33091061
[TBL] [Abstract][Full Text] [Related]
25. Point-of-care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities.
Ochodo EA; Olwanda EE; Deeks JJ; Mallett S
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013208. PubMed ID: 35266555
[TBL] [Abstract][Full Text] [Related]
26. Returning HIV-1 viral load results to participant-selected health facilities in national Population-based HIV Impact Assessment (PHIA) household surveys in three sub-Saharan African Countries, 2015 to 2016.
Saito S; Duong YT; Metz M; Lee K; Patel H; Sleeman K; Manjengwa J; Ogollah FM; Kasongo W; Mitchell R; Mugurungi O; Chimbwandira F; Moyo C; Maliwa V; Mtengo H; Nkumbula T; Ndongmo CB; Vere NS; Chipungu G; Parekh BS; Justman J; Voetsch AC
J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171193
[TBL] [Abstract][Full Text] [Related]
27. Implementation process and challenges of index testing in Côte d'Ivoire from healthcare workers' perspectives.
Mugisha N; Tirera F; Coulibaly-Kouyate N; Aguie W; He Y; Kemper K; Robinson J; N'Goran L; Tuho M; Kouyate S; Doumbia Y; Gloyd S; Kone A
PLoS One; 2023; 18(2):e0280623. PubMed ID: 36753518
[TBL] [Abstract][Full Text] [Related]
28. Optimal timing of viral load monitoring during pregnancy to predict viraemia at delivery in HIV-infected women initiating ART in South Africa: a simulation study.
Lesosky M; Glass T; Mukonda E; Hsiao NY; Abrams EJ; Myer L
J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171179
[TBL] [Abstract][Full Text] [Related]
29. Adaptation of an electronic dashboard to monitor HIV viral load testing in Côte d'Ivoire.
Kirk M; Assoa PH; Iiams-Hauser C; Kouabenan YR; Antilla J; Steele-Lane C; Rossum G; Komena P; Ngatchou PS; Abiola N; Kouakou A; Pongathie A; Koffi JB; Adje C; Perrone LA
Afr J Lab Med; 2021; 10(1):1284. PubMed ID: 34192117
[TBL] [Abstract][Full Text] [Related]
30. Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children.
Rouet F; Sakarovitch C; Msellati P; Elenga N; Montcho C; Viho I; Blanche S; Rouzioux C; Dabis F; Leroy V;
Pediatrics; 2003 Oct; 112(4):e289. PubMed ID: 14523214
[TBL] [Abstract][Full Text] [Related]
31. Specimen origin, type and testing laboratory are linked to longer turnaround times for HIV viral load testing in Malawi.
Minchella PA; Chipungu G; Kim AA; Sarr A; Ali H; Mwenda R; Nkengasong JN; Singer D
PLoS One; 2017; 12(2):e0173009. PubMed ID: 28235013
[TBL] [Abstract][Full Text] [Related]
32. Uptake of routine viral load testing among people living with HIV and its implementation challenges in Yangon region of Myanmar: a mixed-methods study.
Thinn KK; Thekkur P; Kyaw NTT; Aye NS; Zaw TM; Soan P; Hone S; Oo HN
BMJ Open; 2019 Dec; 9(12):e032678. PubMed ID: 31796489
[TBL] [Abstract][Full Text] [Related]
33. Access to HIV Viral Load Testing and Antiretroviral Therapy Switch Practices: A Multicountry Prospective Cohort Study in Sub-Saharan Africa.
Ondoa P; Kim AA; Boender TS; Zhang G; Kroeze S; Wiener J; Rinke de Wit T; Nkengasong J;
AIDS Res Hum Retroviruses; 2020 Nov; 36(11):918-926. PubMed ID: 32722958
[TBL] [Abstract][Full Text] [Related]
34. Increasing rate of TAMs and etravirine resistance in HIV-1-infected adults between 12 and 24 months of treatment: the VOLTART cohort study in Côte d'Ivoire, West Africa.
Messou E; Chaix ML; Gabillard D; Yapo V; Toni TD; Minga A; Kouakou MG; Ouattara E; Rouzioux C; Danel C; Eholie SP; Anglaret X
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):211-9. PubMed ID: 23797690
[TBL] [Abstract][Full Text] [Related]
35. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
36. Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme.
Anaky MF; Duvignac J; Wemin L; Kouakoussui A; Karcher S; Touré S; Seyler C; Fassinou P; Dabis F; N'Dri-Yoman T; Anglaret X; Leroy V
Bull World Health Organ; 2010 Jul; 88(7):490-9. PubMed ID: 20616968
[TBL] [Abstract][Full Text] [Related]
37. Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study.
Iyun V; Technau KG; Vinikoor M; Yotebieng M; Vreeman R; Abuogi L; Desmonde S; Edmonds A; Amorissani-Folquet M; Davies MA;
Lancet HIV; 2021 Jun; 8(6):e353-e362. PubMed ID: 33932330
[TBL] [Abstract][Full Text] [Related]
38. A targeted approach for routine viral load monitoring in Malawian adults on antiretroviral therapy.
Mungwira RG; Divala TH; Nyirenda OM; Kanjala M; Muwalo F; Mkandawire FA; Choko A; Taylor TE; Mallewa J; van Oosterhout JJ; Laufer MK; Laurens MB
Trop Med Int Health; 2018 May; 23(5):526-532. PubMed ID: 29505108
[TBL] [Abstract][Full Text] [Related]
39. Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.
Walenda C; Kouakoussui A; Rouet F; Wemin L; Anaky MF; Msellati P
J Trop Pediatr; 2009 Jun; 55(3):170-6. PubMed ID: 19066169
[TBL] [Abstract][Full Text] [Related]
40. Viral load testing among pregnant women living with HIV in Mutare district of Manicaland province, Zimbabwe.
Musanhu CCC; Takarinda KC; Shea J; Chitsike I; Eley B
AIDS Res Ther; 2022 Nov; 19(1):52. PubMed ID: 36384677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]